Efficacy News and Research

RSS
MicroConstants acquires access to new nanosizing technology

MicroConstants acquires access to new nanosizing technology

Heat therapy using Thermomed device effective for treatment of leishmaniasis

Heat therapy using Thermomed device effective for treatment of leishmaniasis

Taxing less healthful foods may steer adults toward healthier diets

Taxing less healthful foods may steer adults toward healthier diets

FDA invites "Little Women" to present research on dangers of HPV vaccines

FDA invites "Little Women" to present research on dangers of HPV vaccines

Phase III study demonstrates superiority of imiquimod cream 2.5% and 3.75% in treatment of AK

Phase III study demonstrates superiority of imiquimod cream 2.5% and 3.75% in treatment of AK

JAAD publishes Phase III data evaluating safety and efficacy of imiquimod in patients with AK

JAAD publishes Phase III data evaluating safety and efficacy of imiquimod in patients with AK

Herceptin as add-on to standard chemotherapy for gastric cancer earns Decision Resources' gold standard status

Herceptin as add-on to standard chemotherapy for gastric cancer earns Decision Resources' gold standard status

Positive results from INSYS Therapeutics' phase III trial for Fentanyl SL Spray

Positive results from INSYS Therapeutics' phase III trial for Fentanyl SL Spray

Positive results from international study of Oncotype DX breast cancer RS

Positive results from international study of Oncotype DX breast cancer RS

X-spine Systems, Gamma Spine announce exclusive agreement for minimally invasive spinal fixation technology

X-spine Systems, Gamma Spine announce exclusive agreement for minimally invasive spinal fixation technology

Poniard Pharmaceuticals reports net loss of $13.2M for fourth-quarter 2009

Poniard Pharmaceuticals reports net loss of $13.2M for fourth-quarter 2009

Positive data from Argos Therapeutics' AGS-003 Phase 2 trial for mRCC

Positive data from Argos Therapeutics' AGS-003 Phase 2 trial for mRCC

Ricerca Biosciences to acquire Discovery and Preclinical business of MDS Pharma Services

Ricerca Biosciences to acquire Discovery and Preclinical business of MDS Pharma Services

Sigma Life Science extends portfolio of knockout rat models with the release of ADME/Tox applications

Sigma Life Science extends portfolio of knockout rat models with the release of ADME/Tox applications

Nordic Naturals' products surpass all PCB standards set by California's Proposition 65

Nordic Naturals' products surpass all PCB standards set by California's Proposition 65

Presentation of results from open-label extension study of Xenazine

Presentation of results from open-label extension study of Xenazine

Obama administration proposes $715.7M for international FP/RH programs

Obama administration proposes $715.7M for international FP/RH programs

Research group performs randomized study to evaluate efficacy of ICCBco in treatment of lung lesions

Research group performs randomized study to evaluate efficacy of ICCBco in treatment of lung lesions

Peptimmune granted US patent for PI-2301 peptide copolymer in treatment of multiple sclerosis

Peptimmune granted US patent for PI-2301 peptide copolymer in treatment of multiple sclerosis

Poniard Pharmaceuticals' picoplatin Phase 2 study in metastatic CRPC: Positive results

Poniard Pharmaceuticals' picoplatin Phase 2 study in metastatic CRPC: Positive results

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.